Trials / Conditions / Metastatic Castration-Resistant Prostate Cancer Patients
Metastatic Castration-Resistant Prostate Cancer Patients
5 registered clinical trials studyying Metastatic Castration-Resistant Prostate Cancer Patients — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy NCT07514065 | Tasly Pharmaceutical Group Co., Ltd | Phase 1 |
| Recruiting | A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) NCT07103018 | K36 Therapeutics, Inc. | Phase 1 |
| Recruiting | A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection NCT07135102 | Xiaorong Sun | Phase 1 |
| Completed | Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®) NCT03643107 | Allarity Therapeutics | Phase 2 |
| Completed | Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program NCT01786031 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |